Cardiac Pulmonary Cell Regeneration

Currently there are clinical trials around the world being undertaken in many cardiac and pulmonary related fields including;

  • Asthma
  • Post MI Myocardial Infraction
  • Heart Disease
  • Lung Disease

These trials can take between 5 and 10 years to come to fruition, however the overwhelming understanding and results thus far are proving very successful. At Cellf we have studied these treatments and applied what we believe to be the most beneficial, non-invasive and safe protocols as our range of therapies. For more information please look at the many web sites available.

Cellf endeavours to help our patients to make informed decisions and offer the “Pros and Cons” in our full patient consultation process.

There are those in the medical and scientific professions that believe Cell Therapy should be banned until it has had the necessary trials. What the existing trials are showing is that by using the patient’s own cells in a fully enclosed unit there is no chance of rejection or contamination. And in some trials the worst outcome is no outcome. Unlike some treatments that are currently considered safe and effective with terrible side effects.

Below is an exert from:

Though the heart is a tough organ, the damaged portions become unable to pump blood as efficiently as they once could. People who have had a heart attack therefore may face a lifetime of maintenance therapy—medications and other treatments aimed at preventing another heart attack and helping the heart work more efficiently.

A new treatment using stem cells—which have the potential to grow into a variety of heart cell types—could potentially repair and regenerate damaged heart tissue. In a study published last February in The Lancet, researchers treated 17 heart attack patients with an infusion of stem cells. A year after the procedure, the amount of scar tissue had shrunk by about 50%.

Research realities

These results sound dramatic, but are they an indication that we’re getting close to perfecting this therapy? “This is a field where, depending on which investigator you ask, you can get incredibly different answers,” says Dr. Richard Lee, professor of medicine at Harvard Medical School and a leading expert on stem cell therapy.

Feel free to contact us at Cellf for more information about cardiac and pulmonary research.

It is important to remember that although “Cell Regeneration Therapy” is an outpatient procedure and has been seen as a viable treatment to help soothe symptoms of pain, Cellf can neither predict or guarantee success for individual patients who undergo the Therapies. There are potential risks associated with any medical procedure especially where cardiac and pulmonary are concerned. Please discuss this with a medical practitioner prior to undergoing any procedures.